Comparative effectiveness and safety of topiramate versus amitriptyline for the prophylactic management of chronic migraine: a prospective comparative study.

Chronic migraine significantly affects people's lives and well-being. Topiramate and amitriptyline are two common medications for preventing migraines. This study compared their effectiveness and safety in treating chronic migraine. Researchers conducted the study in Lahore, Pakistan, over one year. They enrolled 330 patients who met specific criteria for chronic migraine. The patients were divided into two groups: one receiving topiramate and the other amitriptyline. Researchers measured headache frequency and disability using a specific test. They collected data at the beginning and after four, eight, and twelve weeks. They also noted any side effects experienced by patients during the study. The findings will help doctors make informed treatment decisions for chronic migraine patients. Understanding the effectiveness and safety of these medications is crucial for improving patient care and outcomes. Clinical relevance: This study provides valuable insights for clinicians choosing between topiramate and amitriptyline for chronic migraine prevention.